Kozak genotype frequencies for MI cases, stroke cases, and control subjects
. | TT (%) . | TC (%) . | CC (%) . | Total . | OR3-150 . | (95% CI)3-150 . |
---|---|---|---|---|---|---|
Control subjects | 293 (76.3) | 85 (22.1) | 6 (1.6) | 384 | ||
MI cases | 67 (85.9) | 10 (12.8) | 1 (1.3) | 78 | 0.53 | (0.27-1.05) |
Total stroke cases | 81 (76.4) | 22 (20.8) | 3 (2.8) | 106 | 0.99 | (0.59-1.65) |
Ischemic stroke | 31 (75.6) | 8 (19.5) | 2 (4.9) | 41 | 0.89 | (0.44-1.82) |
Hemorrhagic stroke | 41 (75.9) | 13 (24.1) | 0 | 54 | 1.01 | (0.51-1.99) |
. | TT (%) . | TC (%) . | CC (%) . | Total . | OR3-150 . | (95% CI)3-150 . |
---|---|---|---|---|---|---|
Control subjects | 293 (76.3) | 85 (22.1) | 6 (1.6) | 384 | ||
MI cases | 67 (85.9) | 10 (12.8) | 1 (1.3) | 78 | 0.53 | (0.27-1.05) |
Total stroke cases | 81 (76.4) | 22 (20.8) | 3 (2.8) | 106 | 0.99 | (0.59-1.65) |
Ischemic stroke | 31 (75.6) | 8 (19.5) | 2 (4.9) | 41 | 0.89 | (0.44-1.82) |
Hemorrhagic stroke | 41 (75.9) | 13 (24.1) | 0 | 54 | 1.01 | (0.51-1.99) |
MI indicates myocardial infarction; OR, odds ratio; CI, confidence interval.
OR and 95% CI calculated for presence of C allele (homozygous or heterozygous) compared with TT genotype, and adjusted for age.